NG-Test® CARBA 5 – AMR Diagnostics in 15 minutes
NG-Test® CARBA 5 is a multiplex lateral flow immunoassay for the rapid detection and differentiation of KPC, OXA-48, VIM, IMP and NDM in less than 15 minutes
The NG-Test® CARBA-5 can be easily implemented into any laboratory settings as it requires minimal hands-on time and no instrumentation is required.
Technology:
Microorganisms:
Application:
Development stage:
- Infection prevention
- Antimicrobial stewardship
- Microbial diagnostics
- Antimicrobial compound/strategy
- Removal antibiotics/bacteria
Microorganisms:
- Bacteria
- Viruses
- Fungi
- Yeasts
- Parasites
Application:
- Human
- Veterinary
- AgriFood
- Environmental
- Other
Development stage:
- Development
- Marketed product
- Research
- Validation
- Market entry
Organization:
Partnering:
Funding organisation:
Infectious disease area:
Geographic origin:
- Company
- Academia
- Institute
- NGO
- Government
Partnering:
- License
- Co-develop
- Outsource
- Sell
- Joint Venture
Funding organisation:
- OTHER / NA
- CARB-X
- FIND
- GARDP
- REPAIR
Infectious disease area:
- UTI
- BSI
- RTI
- STI
- GII
- SSTI
- CNSI
- IAI
- SSI
Geographic origin:
- Eurasia
- North America
- South America
- Africa
- Oceania
Diagnostic companies in the field of Clinical Microbiology Diagnostics interested in expanding the product portfolio with a global leading product line in the AMR Diagnostics segment
NG Biotech is an innovative biotech company developing & manufacturing RAPID diagnostic tests for the easy, fast, accurate detection of expressed AMR.
NG Biotech portfolio includes LFIA Rapid Tests for Diagnostic for Carbapenemase, Extended-Spectrum Beta-Lactamase Resistance (CTX-M) and Colistin Resistance (MCR-1)
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!